<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04484090</url>
  </required_header>
  <id_info>
    <org_study_id>OHH-FE-0.1</org_study_id>
    <nct_id>NCT04484090</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Ohhmed Treatments for the Improvement of Erectile Dysfunction - A Feasibility Study</brief_title>
  <official_title>Safety and Efficacy of Ohhmed Treatments for the Improvement of Erectile Dysfunction - A Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>OHH-MED Medical Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>OHH-MED Medical Ltd</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Erectile dysfunction, the persistent inability to achieve or maintain an erection sufficient
      for satisfactory sexual performance, is estimated to affect up to 30 million men in the
      United States. The disorder is age-associated. The available treatments include oral therapy,
      vacuum-constriction devices; shockwave therapy, intracavernosal injections of vasoactive
      agents, including alprostadil (prostaglandin E1, transurethral delivery of alprostadil,
      Implantation of penile prostheses.

      The OhhMed Company has developed the OhhMed device that provides treatments for improvement
      of erectile function in patients with erectile dysfunction. This study assess the safety,
      efficacy, ease of use, and satisfaction of the OhhMed device by men with mild to moderate
      erectile dysfunction.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 20, 2019</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in erectile function (EF)</measure>
    <time_frame>Baseline to 1 month post intervention</time_frame>
    <description>The International Index for Erectile Function (IIEF) questionnaire will be administered. This is a 15 item tool; 6 ask questions addressing Erectile function over the previous 4 weeks. Scores from 0-30 can be obtained in this domain. Scores are interpreted as follows: 0-6 = Severe dysfunction, 7-12 = Moderate dysfunction, 13-18 = mild-moderate dysfunction, 19-24 = mild dysfunction, 25-30 = No dysfunction</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Erectile Dysfunction</condition>
  <arm_group>
    <arm_group_label>OhhMed</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment with OhhMed device for improving erectile function for men with erectile dysfunction</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>OhhMed</intervention_name>
    <description>The treatment provided by the OhhMed device is indicated for improving the erectile function in men with erectile dysfunction</description>
    <arm_group_label>OhhMed</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  IIEF-EF score of 11-24 with or without the use of medication (PDE5 inhibitors).

          -  Erectile dysfunction for at least 3- months

          -  Steady relationship for at least 3-months.

          -  patient without sensory disorders

          -  patient with established organic of erectile dysfunction

        Exclusion Criteria:

          -  investigator's impression of expected poor patient compliance or anatomic inadequacy
             (penile size/girth)

          -  Premature ejaculation

          -  Any psychiatric disorder

          -  Epilepsy

          -  Peyronie 's disease/ penile curvature

          -  Coagulopathy

          -  Any tumor in the pelvic or penile region within the last 3 years
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>The OhhMed device provide treatments for improvement of erectile dysfunction</gender_description>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ilan Gruenwald, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rambam Medical Center, Haifa Israel</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rambam Medical center</name>
      <address>
        <city>Haifa</city>
        <zip>3525408</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 21, 2020</study_first_submitted>
  <study_first_submitted_qc>July 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 23, 2020</study_first_posted>
  <last_update_submitted>July 21, 2020</last_update_submitted>
  <last_update_submitted_qc>July 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Erectile dysfunction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Erectile Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

